Determination of beta S haplotypes in patients with sickle-cell anemia in the state of Rio Grande do Norte, Brazil

βS haplotypes were studied in 47 non-related patients with sickle-cell anemia from the state of Rio Grande do Norte, Brazil. Molecular analysis was conducted by PCR/RFLP using restriction endonucleases XmnI, HindIII, HincII and HinfI to analyze six polymorphic sites from the beta cluster. Twenty-seven patients (57.5 percent) were identified with genotype CAR/CAR, 9 (19.1 percent) CAR/BEN, 6 (12.8 percent) CAR/CAM, 1 (2.1 percent) BEN/BEN, 2 (4.3 percent) CAR/Atp, 1 (2.1 percent) BEN/Atp and 1 (2.1 percent) with genotype Atp/Atp. The greater frequency of Cameroon haplotypes compared to other Brazilian states suggests the existence of a peculiarity of African origin in the state of Rio Grande do Norte.

Characterization of beta-thalassemia mutations in patients from the state of Rio Grande do Norte, Brazil

35 unrelated individuals were studied for characterization as either heterozygous or homozygous for beta-thalassemia. Molecular analysis was done by PCR/RFLP to detect the mutations most commonly associated with beta-thalassemia (β0IVS-I-1, β+IVS-I-6, and β039). In the patients who showed none of these mutations, the beta-globin genes were sequenced. Of the 31 heterozygous patients, 13 (41.9 percent) had the β+IVS-I-6 mutation, 15 (48.4 percent) the β0IVS-I-1 mutation, 2 (6.5 percent) the β+IVS-I-110 mutation and 1 (3.2 percent) the β+IVS-I-5 mutation. IVS-I-6 was detected in the four homozygotes. The mutation in codon 39, often found in previous studies in Brazil, was not detected in the present case. This is the first study aiming at identifying mutations that determine beta-thalassemia in the state of Rio Grande do Norte.

Estudo de polimorfismos genéticos da família ABC: efeitos na expressão gênica e na resposta farmacológica a atorvastatina / Genetic polymorphisms study of the ABC family: effects in the gene expression and in the pharmacological response to atorvastatin

As proteínas da ABC são uma família de transportadores de membrana que participam no transporte de lipídeos e na biodisponibilidade de drogas. Alterações em genes dessas proteínas também têm sido associadas a diferenças na resposta a vários fármacos. Neste estudo, foram avaliados os efeitos dos polimorfismos dos genes MDR1 (C3435T e G2677T/A) e MRP1 (G2012T) na expressão de RNAm e concentrações séricas dos lipídeos, em 76 indivíduos com hipercolesterolemia primária, tratados com atorvastatina (10mg/dia/4sem). DNA e RNA foram obtidos a partir de células mononucleares do sangue perférico. Os polimorfismos genéticos foram analisados por PCR-RFLP e a expressão de RNAm foi quantificada por RT-PCR...